![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
New
Arcoxia Data (On The Pharm)
In this post, the blogger writes about recently released data on Merck's investigational
osteoporosis drug, Arcoxia (etoricoxib). The study showed Arcoxia had fewer
gastrointestinal side effects than diclofenac.
"The billion dollar question remains how Arcoxia affects the heart. One study suggests that it's more friendly than diclofenac, but a better question would be how it fares against placebo. Though if it's 'better' than diclofenac a drug that's been on the market for years does that mean it's a shoe-in for FDA approval when the time comes, regardless of how it fares against placebo?"
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct